Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients

Clinical trial NCT00397189 · COMPLETED

Trial details

NCT number: NCT00397189
Sponsor: Neurim Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2006-10-01
Primary completion: 2008-12-01
Enrollment: 930

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.